Overall rank by patents
#31,898
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 10 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G02B (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS).
The verdict
Horiba holds 8 US patents across 10 technology areas, rank #31,898 of 50,000 tracked assignees.
Horiba France SAS has been granted 8 US utility patents between 2020 and 2025, placing Horiba France SAS at rank #31,898 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.3 claims per patent with primary concentration in G02B (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS). As a Foreign Corporation, Horiba France SAS is one of the more focused assignees in the PatentsView dataset. By volume, Horiba sits between Holland Bloorview KIDS Rehabilitation Hospital (8 patents, rank #31,894) and HRST, Inc. (8 patents, rank #31,902) - the closest US assignees by grant volume. The composite Innovation Score of 29.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Horiba France SAS's 15.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Horiba France SAS against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
HOLLAND BLOORVIEW KIDS REHABILITATION HOSPITAL
8 patents
HOLWEG GROUP
8 patents
HONDA TSUSHIN KOGYO CO., LTD.
8 patents
HOPPECKE BATTERIEN GMBH & CO. KG
8 patents
HOSOKAWA ALPINE Aktiengesellschaft
8 patents
HOWA PLASTICS CO., LTD.
8 patents
HRM Enterprises, Inc.
8 patents
HRST, Inc.
8 patents
HORIBA FRANCE SAS
8 patents
What this shows Horiba holds 8 patents at rank #31,898, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,898 in granted patent volume.
Other assignees with the most granted patents in Horiba's primary technology class.
Horiba's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 70% higher than 30% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 37.5% |
| 2021 | 2 | 25.0% |
| 2024 | 1 | 12.5% |
| 2025 | 2 | 25.0% |
Top 10 of 10 technology areas
Overall rank by patents
#31,898
Across all tracked assignees
29.3 out of 100
How to use this portfolio
Horiba's 8 grants land it in the top 70% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.